Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
The American Medical Association has unveiled a governance framework to guide the safe use of agentic AI in healthcare. Built around four key questions — covering what AI can do, how it performs, what it's permitted to do, and who's accountable — the framework aims to keep physicians central as autonomous AI tools rapidly expand into clinical workflows, all while federal regulation struggles to keep pace.
The American Medical Association (AMA) has released a governance framework to ensure agentic AI tools are used safely and responsibly in clinical settings. Unlike standard generative AI, agentic AI can autonomously complete complex, multi-step tasks — think ambient documentation, diagnostics, and patient monitoring — without constant human oversight. That autonomy raises the stakes: a flawed or biased decision could harm patients before a clinician even notices.
The framework centers on four guiding questions: What clinical function is the AI performing? What evidence supports its performance, and what happens if it fails? What should it be permitted to do, and under what conditions? And who is responsible for its outcomes? The AMA says these questions will shape its collaboration with other organizations to keep AI deployment aligned with patient safety.
By the Numbers:
Why it matters: With federal AI regulation lagging and a patchwork of state laws emerging, the AMA's framework offers a much-needed industry anchor — helping healthcare organizations navigate the agentic AI boom without sacrificing patient safety or accountability.
